Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Sweden
/
Healthcare
Create a narrative
Senzime Community
OM:SEZI Community
1
Narratives
written by author
0
Comments
on narratives written by author
2
Fair Values set
on narratives written by author
Create a narrative
Senzime
Popular
Undervalued
Overvalued
Community Investing Ideas
Senzime
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
US And European EMG Guidelines Will Spur TetraGraph Adoption
Key Takeaways Mandated EMG technology in Europe and the U.S. and new product launches set a strong growth trajectory, boosting sales and revenue. Expansion in the U.S. market and growth in Asia, coupled with strategic partnerships, enhance market penetration and diversify revenue streams.
View narrative
SEK 12.00
FV
57.9% undervalued
intrinsic discount
80.88%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
3 days ago
author updated this narrative
Your Valuation for
SEZI
SEZI
Senzime
Your Fair Value
SEK
Current Price
SEK 5.05
38.5% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-173m
645m
2015
2018
2021
2024
2025
2027
2030
Revenue SEK 645.4m
Earnings SEK 94.1m
Advanced
Set Fair Value